After de novo assembly using Trinity, how to calculate coverage??
-
Last edited by ankitarathore; 05-21-2013, 12:31 AM. -
Hi, I want to run a de novo with trinity. Which command should I use to start? I have single reads in fq
thanks -
You should check http://trinityrnaseq.sourceforge.net/ for details.
But something like the following should get you running:
Trinity --seqType fq --JM 100G --single reads.fq --CPU 6
Check your available RAM memory and number of cores to assign correctly the JM and CPU parameters. Substitute "reads.fq" for your read file.Comment
-
If RAM is 1GB then what to do?Comment
-
Not much (at least not in terms of de novo assembly). Unless the genome you are working on is the size of a small bacteriopahge.Originally posted by Nanu View PostComment
-
Genomax,
I executed the fastqc , fastx and indexing the reference genome through Bowtie. When i executing the tophat2..it created the accepted.bam and unmapped.bam, align-summary.txt, logs etc...
Here I got only 1 KB size of accepted hits..while unmapped.bam is 200MB in size. i have heterologous reference genome. I downloaded the genome from Ensembl database. I have to find the novel gene, its expression.
Is any particular pipeline for roche transcriptome data?
I am trying to evaluate as denovo through trinity for roche transcriptome data analysis. here increased the RAM as 6GB.
Please help me..Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment